Copyright: ©Author(s) 2026.
World J Gastroenterol. Jun 7, 2026; 32(21): 118057
Published online Jun 7, 2026. doi: 10.3748/wjg.v32.i21.118057
Published online Jun 7, 2026. doi: 10.3748/wjg.v32.i21.118057
Figure 3 Subgroup analysis of the association between healthy sleep score and metabolic dysfunction-associated steatotic liver disease.
The comprehensive model was adjusted for age, gender, physical exercise, smoking, education, body mass index (BMI), hypertension and diabetes. The model was adjusted for gender, physical exercise, smoking, education, BMI, hypertension and diabetes when age categories (< 50 years and ≥ 50 years) was analyzed in group. The model was adjusted for age, physical exercise, smoking, education, BMI, hypertension and diabetes when sex categories (male and female) was analyzed in group. The model was adjusted for age, sex, physical exercise, smoking, education, hypertension and diabetes when BMI categories (under-weight and normal weight BMI ≤ 24.9 kg/m2, overweight and obesity BMI > 24.9 kg/m2) was analyzed in group. Data are presented as the logistic regression index (95%CI). BMI: Body mass index.
- Citation: Yu QT, Lin YY, Gui ZH, Duan HL, Yang JJ, Meng Y, Peng XT, Liu L, Wan H, Shen J. Mediating roles of insulin resistance and inflammatory markers between healthy sleep scores and metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2026; 32(21): 118057
- URL: https://www.wjgnet.com/1007-9327/full/v32/i21/118057.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i21.118057